倍益康(870199) - 投资者关系活动记录表

Group 1: Financial Performance - In 2024, the company achieved operating revenue of 291 million yuan, with a net profit attributable to shareholders of 27.78 million yuan, and total assets of 690 million yuan as of December 31, 2024 [4] - The company's revenue decreased by 12.78% year-on-year, with domestic revenue dropping by 38.27% and overseas revenue increasing by 45% [10] - The net cash flow from operating activities in 2024 was approximately 29.99 million yuan, a decrease of 47% compared to 2023 [8] Group 2: Investment and Assets - In 2024, the company added fixed assets primarily for production equipment and to solidify its upstream supply chain, enhancing production capacity and efficiency [4] - The company currently holds 19 medical device registration certificates covering various fields such as electrotherapy and oxygen therapy [5] Group 3: Product Development and Innovation - The company has made significant progress in new product development, with several products receiving regulatory approval, including the portable pneumatic massage system, which has also passed FDA 510(k) review [4] - Future product plans include the development of various rehabilitation devices, with a goal to launch 7-8 new products annually [9] Group 4: Strategic Goals for 2025 - The company aims to expand its market presence internationally and enhance its product offerings through innovation and brand building [5][6] - Key operational goals include optimizing production processes, improving product quality, and reducing production costs to enhance profitability [6] Group 5: Brand and Market Positioning - The company is focused on reducing reliance on a single product, with the muscle massager accounting for 89.72% of main business revenue [12] - Strategies to enhance brand competitiveness include increasing brand awareness through advertising and improving product quality through continuous R&D investment [13] Group 6: Cost Control Measures - The company has implemented advanced production equipment and automated production lines to improve efficiency and reduce unit production costs [14] - Supply chain management has been optimized to ensure timely supply and stable quality of raw materials, thereby reducing procurement costs [14]